These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28420072)

  • 41. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
    Shah D; Kiran R; Wanchu A; Bhatnagar A
    Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary mononuclear cell and disease activity of systemic lupus erythematosus.
    Chan RW; Lai FM; Li EK; Tam LS; Chung KY; Chow KM; Li PK; Szeto CC
    Lupus; 2006; 15(5):262-7. PubMed ID: 16761499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus.
    Wang G; Pierangeli SS; Willis R; Gonzalez EB; Petri M; Khan MF
    PLoS One; 2016; 11(10):e0164739. PubMed ID: 27749917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J; Zhang L; Yan M; Liu Z; Xue L
    Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms.
    Avalos I; Chung CP; Oeser A; Milne GL; Morrow JD; Gebretsadik T; Shintani A; Yu C; Stein CM
    Lupus; 2007; 16(3):195-200. PubMed ID: 17432105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidative stress leads to reduction of plasmalogen serving as a novel biomarker for systemic lupus erythematosus.
    Hu C; Zhou J; Yang S; Li H; Wang C; Fang X; Fan Y; Zhang J; Han X; Wen C
    Free Radic Biol Med; 2016 Dec; 101():475-481. PubMed ID: 27836780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study.
    Mezzaroba L; Simão ANC; Oliveira SR; Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
    Mol Neurobiol; 2020 May; 57(5):2167-2178. PubMed ID: 31970657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sub-acute restraint stress progressively increases oxidative/nitrosative stress and inflammatory markers while transiently upregulating antioxidant gene expression in the rat hippocampus.
    Chen HC; Lee JK; Yip T; Sernia C; Lavidis NA; Spiers JG
    Free Radic Biol Med; 2019 Jan; 130():446-457. PubMed ID: 30445125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficiency of IRE1 and PERK signal pathways in systemic lupus erythematosus.
    Wang J; Cheng Q; Wang X; Zu B; Xu J; Xu Y; Zuo X; Shen Y; Wang J; Shen Y
    Am J Med Sci; 2014 Dec; 348(6):465-73. PubMed ID: 25226532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.
    Tselios K; Sarantopoulos A; Gkougkourelas I; Boura P
    Clin Exp Rheumatol; 2014; 32(5):630-9. PubMed ID: 25197969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
    Batuca JR; Ames PR; Amaral M; Favas C; Isenberg DA; Delgado Alves J
    Rheumatology (Oxford); 2009 Jan; 48(1):26-31. PubMed ID: 19000993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
    Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
    Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basophil count, a marker for disease activity in systemic lupus erythematosus.
    Liang P; Tang Y; Fu S; Lv J; Liu B; Feng M; Li J; Lai D; Wan X; Xu A
    Clin Rheumatol; 2015 May; 34(5):891-6. PubMed ID: 25403252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.